194 related articles for article (PubMed ID: 23040637)
1. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy.
Luo Y; Chihara Y; Fujimoto K; Sasahira T; Kuwada M; Fujiwara R; Fujii K; Ohmori H; Kuniyasu H
Eur J Cancer; 2013 Feb; 49(3):741-51. PubMed ID: 23040637
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages.
Kuniyasu H; Yano S; Sasaki T; Sasahira T; Sone S; Ohmori H
Am J Pathol; 2005 Mar; 166(3):751-60. PubMed ID: 15743787
[TBL] [Abstract][Full Text] [Related]
4. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
5. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
van Beijnum JR; Buurman WA; Griffioen AW
Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
[TBL] [Abstract][Full Text] [Related]
6. HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer.
Luo Y; Ohmori H; Fujii K; Moriwaka Y; Sasahira T; Kurihara M; Tatsumoto N; Sasaki T; Yamashita Y; Kuniyasu H
Eur J Cancer; 2010 Mar; 46(4):791-9. PubMed ID: 20018503
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
[TBL] [Abstract][Full Text] [Related]
8. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
[TBL] [Abstract][Full Text] [Related]
9. Role of high mobility group box 1 (HMGB1) in wound healing.
Zhang Q; O'Hearn S; Kavalukas SL; Barbul A
J Surg Res; 2012 Jul; 176(1):343-7. PubMed ID: 21872885
[TBL] [Abstract][Full Text] [Related]
10. Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer.
Kusume A; Sasahira T; Luo Y; Isobe M; Nakagawa N; Tatsumoto N; Fujii K; Ohmori H; Kuniyasu H
Pathobiology; 2009; 76(4):155-62. PubMed ID: 19571604
[TBL] [Abstract][Full Text] [Related]
11. Role of cell-cell interactions in high mobility group box 1 cytokine activity in human peripheral blood mononuclear cells and mouse splenocytes.
Kohka Takahashi H; Sadamori H; Liu K; Wake H; Mori S; Yoshino T; Yamamoto Y; Yamamoto H; Nishibori M
Eur J Pharmacol; 2013 Feb; 701(1-3):194-202. PubMed ID: 23228930
[TBL] [Abstract][Full Text] [Related]
12. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis.
Kawabata H; Setoguchi T; Yone K; Souda M; Yoshida H; Kawahara K; Maruyama I; Komiya S
Spine (Phila Pa 1976); 2010 May; 35(11):1109-15. PubMed ID: 20195207
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells.
Thierry S; Gozlan J; Jaulmes A; Boniface R; Nasreddine N; Strauss F; Maréchal V
AIDS; 2007 Jan; 21(3):283-92. PubMed ID: 17255735
[TBL] [Abstract][Full Text] [Related]
14. Exogenous high-mobility group box 1 inhibits apoptosis and promotes the proliferation of lewis cells via RAGE/TLR4-dependent signal pathways.
Xu X; Zhu H; Wang T; Sun Y; Ni P; Liu Y; Tian S; Amoah Barnie P; Shen H; Xu W; Xu H; Su Z
Scand J Immunol; 2014 Jun; 79(6):386-94. PubMed ID: 24673192
[TBL] [Abstract][Full Text] [Related]
15. The role of HMGB1/RAGE in inflammatory cardiomyopathy.
Volz HC; Kaya Z; Katus HA; Andrassy M
Semin Thromb Hemost; 2010 Mar; 36(2):185-94. PubMed ID: 20414834
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
Lee W; Ku SK; Bae JW; Bae JS
Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
[TBL] [Abstract][Full Text] [Related]
18. Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells.
Dumitriu IE; Baruah P; Bianchi ME; Manfredi AA; Rovere-Querini P
Eur J Immunol; 2005 Jul; 35(7):2184-90. PubMed ID: 15915542
[TBL] [Abstract][Full Text] [Related]
19. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
Shimazaki J; Matsumoto N; Ogura H; Muroya T; Kuwagata Y; Nakagawa J; Yamakawa K; Hosotsubo H; Imamura Y; Shimazu T
Shock; 2012 Jun; 37(6):634-8. PubMed ID: 22392147
[TBL] [Abstract][Full Text] [Related]
20. High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.
Urbonaviciute V; Voll RE
J Intern Med; 2011 Oct; 270(4):309-18. PubMed ID: 21793951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
